We therefore present clinical data from nine patients with CD30‐positive cutaneous PTCL from two centers (Hamburg, Würzburg) who received monotherapy or combination therapy with BV. Here, TNFRSF8 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.